News and Announcements
Connexion Media Expands Contract with General Motors to Canada and Mexico
- Published May 22, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Connexion Media Limited (ASX; CXZ), an innovator in the connected car market, is pleased to announce that is has expanded its contract with General Motors to launch a customised Commercial Link telematics solution to Canada and Mexico. The service will be an embedded hardware solution that links to the software that powers Commercial Link.
KEY TAKEAWAYS:
- Connexion Media has won a territory expansion to its contract with General Motors to launch Commercial Link in Canada and Mexico
- General Motors to pay for all customisation work undertaken
- GM’s Commercial Link Service will now be available in three countries, following Connexion’s launch in the USA in 2016
- General Motors plans to launch the new service in both Canada and Mexico in late 2017
- North America expansion represents further validation for Connexion.
The Company is not able to disclose further details at this stage as they are considered commercially sensitive.
George Parthimos, Executive Chairman of Connexion Media, said: “Expanding our agreement to develop a customised Commercial Link telematics solution for GM to launch in Canada and Mexico is a great opportunity for Connexion. It demonstrates strong validation of the Company’s innovative connected car solutions from a leading and global automaker.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
